RUNX1 and precursor B-cell acute lymphoblastic leukemia: Finally, the incidence of the B-ALL associated PFG as measured in 500 UCB probands was estimated as follows: BCR-ABL1 at 5%, ETV6-RUNX1 at 2.4%, and MLL-AF4 at 0.8% (Figure 1C).